| |
| |
|
| Insider
Information: |
Mcneill Jonathan |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
139,408 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,549,328 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
139,408 |
|
|
| Total
Value |
$3,549,328 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-11 |
139,408 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-11 |
4 |
AS |
$25.48 |
$499,842 |
D/D |
(19,601) |
139,408 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-11 |
4 |
OE |
$5.54 |
$98,751 |
D/D |
17,825 |
159,009 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-08 |
4 |
AS |
$25.46 |
$2,361,531 |
D/D |
(90,000) |
141,184 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-08 |
4 |
OE |
$5.54 |
$498,600 |
D/D |
90,000 |
231,184 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-07 |
4 |
AS |
$25.85 |
$62,919 |
D/D |
(2,434) |
141,184 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-01 |
4 |
OE |
$0.73 |
$17,710 |
D/D |
24,260 |
167,878 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-03-01 |
4 |
AS |
$28.25 |
$694,495 |
D/D |
(24,260) |
143,618 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-02-29 |
4 |
AS |
$27.50 |
$117,370 |
D/D |
(4,268) |
143,618 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-02-29 |
4 |
OE |
$0.73 |
$3,116 |
D/D |
4,268 |
147,886 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-26 |
4 |
OE |
$0.73 |
$14,600 |
D/D |
20,000 |
163,618 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-26 |
4 |
AS |
$24.52 |
$490,510 |
D/D |
(20,000) |
143,618 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-04 |
4 |
AS |
$18.04 |
$36,242 |
D/D |
(2,009) |
143,618 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-04 |
4 |
OE |
$0.73 |
$1,467 |
D/D |
2,009 |
145,627 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-03 |
4 |
AS |
$18.34 |
$337,062 |
D/D |
(17,991) |
143,618 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-03 |
4 |
OE |
$0.73 |
$13,133 |
D/D |
17,991 |
161,609 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-02 |
4 |
AS |
$13.10 |
$155,890 |
D/D |
(11,900) |
143,618 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-12-11 |
4 |
AS |
$10.72 |
$13,346 |
D/D |
(1,245) |
155,518 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
96,158 |
156,763 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-09-18 |
4 |
AS |
$9.41 |
$11,866 |
D/D |
(1,261) |
60,605 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-09-12 |
4 |
S |
$10.41 |
$13,179 |
D/D |
(1,266) |
61,866 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-06-13 |
4 |
AS |
$12.43 |
$15,649 |
D/D |
(1,259) |
63,132 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-06-12 |
4 |
AS |
$13.00 |
$13,000 |
D/D |
(1,000) |
64,391 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-01-18 |
4 |
AS |
$14.03 |
$140,300 |
D/D |
(10,000) |
67,600 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-01-18 |
4 |
OE |
$0.73 |
$7,300 |
D/D |
10,000 |
77,600 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-01-09 |
4 |
AS |
$11.57 |
$348,836 |
D/D |
(30,150) |
67,600 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
